• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Theratechnologies Inc. - Common Shares (NQ:THTX)

3.390 UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Theratechnologies Inc. - Common Shares

< Previous 1 2 3 4 Next >
News headline image
Theratechnologies Announces Completion of Acquisition by Future Pak
September 25, 2025
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies Receives Final Court Approval of Proposed Plan of Arrangement to Be Acquired by Future Pak
September 16, 2025
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies Shareholders Approve Proposed Plan of Arrangement to Be Acquired by Future Pak
September 12, 2025
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy
September 05, 2025
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies Announces Independent Proxy Advisor Firms ISS and Glass Lewis Recommend Shareholders Vote “FOR” the Proposed Plan of Arrangement with Future Pak
September 02, 2025
From Theratechnologies
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: TEGNA Inc. (NYSE - TGNA), NorthWestern Energy Group, Inc. (Nasdaq - NWE), Theratechnologies Inc. (Nasdaq - THTX), Dogwood State Bank (OTC - DSBX)
August 19, 2025
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Theratechnologies Announces Filing of Special Meeting Materials and Receipt of Interim Order in Relation to its Acquisition by CB Biotechnology, an Affiliate of Future Pak
August 18, 2025
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies Reports Financial Results for the Second Quarter 2025
July 09, 2025
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies to Announce Second Quarter 2025 Financial Results
July 03, 2025
From Theratechnologies
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Olo Inc. (NYSE - OLO), Theratechnologies Inc. (Nasdaq - THTX), Guaranty Bancshares, Inc. (NYSE - GNTY), MRC Global Inc. (NYSE - MRC)
July 03, 2025
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Theratechnologies enters into Definitive Agreement to be Acquired by CB Biotechnology, an Affiliate of Future Pak
July 02, 2025
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies Reports on its Annual Meeting of Shareholders
May 29, 2025
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV
May 02, 2025
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies Provides Update on Sale Process
April 15, 2025
From Theratechnologies
Via GlobeNewswire
News headline image
Soleus Capital Issues Letter to The Board of Theratechnologies
April 12, 2025
From Soleus Capital Management, L.P.
Via Business Wire
News headline image
Theratechnologies Responds to Future Pak’s Press Release and Announces Exclusive Discussions with Another Potential Acquiror for the Sale of the Company
April 11, 2025
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies Reports Financial Results for the First Quarter 2025 and Reviews Key Achievements
April 09, 2025
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies Receives FDA Approval of Prior Approval Supplement (PAS) for EGRIFTA SV® sBLA
April 08, 2025
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies to Announce First Quarter 2025 Financial Results and Provide Business Update
April 03, 2025
From Theratechnologies
Via GlobeNewswire
News headline image
Driving the Future of Healthcare HIT, OSRH, THTX, LPTX, CSDX, Innovations in Health Insurance, Virtual Care, Oncology, and Chronic Disease Treatment
March 26, 2025
Via AB Newswire
Topics Artificial Intelligence
News headline image
Theratechnologies Receives FDA Approval for EGRIFTA WR™ (Tesamorelin F8) to Treat Excess Visceral Abdominal Fat in Adults with HIV and Lipodystrophy
March 25, 2025
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies Presents Encouraging Virologic Suppression Data from the PROMISE-US Trial of Ibalizumab at CROI
March 12, 2025
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies CROI Presentation Highlights Limitations of Using BMI to Assess Cardiovascular (CV) Risk in People with HIV
March 12, 2025
Study Demonstrates Excess Visceral Abdominal Fat Drives CV Risk 
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2024
February 26, 2025
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update
February 14, 2025
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies Resumes Distribution of EGRIFTA SV®
February 13, 2025
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies Provides Update on EGRIFTA SV® Supply
January 09, 2025
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing Environment
December 18, 2024
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies Receives March 2025 PDUFA Goal Date for Updated Tesamorelin F8 Formulation sBLA
December 10, 2024
From Theratechnologies
Via GlobeNewswire
News headline image
Theratechnologies Announces Preliminary Tolerability and Efficacy Data from Phase 1b, Dose-Ranging Trial of Sudocetaxel Zendusortide in Patients with Advanced Ovarian Cancer
December 09, 2024
From Theratechnologies
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap